Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Lyerly

Showing results (21-30 of 218) with videos related to

Pageof 22
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 10, 2023
Beyond Neoantigens: Antigens Derived from Tumor Drivers as Cancer Vaccine TargetsErika J Crosby, Zachary C Hartman, H Kim Lyerly
Molecular Biotechnology|September 19, 2003
Preparation of peptide-loaded dendritic cells for cancer immunotherapyMichael A Morse, Tim Clay, Kirsten Colling, et al.
Seminars in Oncology|May 19, 2012
Novel recombinant alphaviral and adenoviral vectors for cancer immunotherapyTakuya Osada, Michael A Morse, Amy Hobeika, et al.
American Journal of Preventive Medicine|February 19, 2013
Minimization of heatwave morbidity and mortalityJulia Kravchenko, Amy P Abernethy, Maria Fawzy, et al.
Plos One|May 26, 2012
Evaluating the number of stages in development of squamous cell and adenocarcinomas across cancer sites using human population-based cancer modelingJulia Kravchenko, Igor Akushevich, Amy P Abernethy, et al.
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
Recent areas of development for dendritic cell vaccinesMichael A Morse, Steve Chui, Timothy M Clay, et al.
Expert Opinion on Biological Therapy|January 9, 2003
Immunoregulatory T cells in cancer immunotherapyMichael A Morse, Timothy M Clay, Paul Mosca, et al.
International Immunology|July 20, 2005
Ex vivo expanded human CD4+ regulatory NKT cells suppress expansion of tumor antigen-specific CTLsTakuya Osada, Michael A Morse, H Kim Lyerly, et al.
Immunotherapy|October 15, 2014
Designing effective vaccines for colorectal cancerSandip P Patel, Takuya Osada, H Kim Lyerly, et al.
Nature Clinical Practice. Oncology|November 3, 2005
Recent developments in therapeutic cancer vaccinesMichael A Morse, Stephen Chui, Amy Hobeika, et al.
Pageof 22

Showing results (21-30 of 218) with videos related to

Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 10, 2023
Beyond Neoantigens: Antigens Derived from Tumor Drivers as Cancer Vaccine TargetsErika J Crosby, Zachary C Hartman, H Kim Lyerly
Molecular Biotechnology|September 19, 2003
Preparation of peptide-loaded dendritic cells for cancer immunotherapyMichael A Morse, Tim Clay, Kirsten Colling, et al.
Seminars in Oncology|May 19, 2012
Novel recombinant alphaviral and adenoviral vectors for cancer immunotherapyTakuya Osada, Michael A Morse, Amy Hobeika, et al.
American Journal of Preventive Medicine|February 19, 2013
Minimization of heatwave morbidity and mortalityJulia Kravchenko, Amy P Abernethy, Maria Fawzy, et al.
Plos One|May 26, 2012
Evaluating the number of stages in development of squamous cell and adenocarcinomas across cancer sites using human population-based cancer modelingJulia Kravchenko, Igor Akushevich, Amy P Abernethy, et al.
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
Recent areas of development for dendritic cell vaccinesMichael A Morse, Steve Chui, Timothy M Clay, et al.
Expert Opinion on Biological Therapy|January 9, 2003
Immunoregulatory T cells in cancer immunotherapyMichael A Morse, Timothy M Clay, Paul Mosca, et al.
International Immunology|July 20, 2005
Ex vivo expanded human CD4+ regulatory NKT cells suppress expansion of tumor antigen-specific CTLsTakuya Osada, Michael A Morse, H Kim Lyerly, et al.
Immunotherapy|October 15, 2014
Designing effective vaccines for colorectal cancerSandip P Patel, Takuya Osada, H Kim Lyerly, et al.
Nature Clinical Practice. Oncology|November 3, 2005
Recent developments in therapeutic cancer vaccinesMichael A Morse, Stephen Chui, Amy Hobeika, et al.
Pageof 22